ACCESSION: MSBNK-SMB_Measured-HSA015P0199014
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 21
COMMENT: RAW_SPEC {'EL16_pos_1377': {'bp': 219699.0, 'sum': 1113300.0}, 'EL01_pos_1378': {'bp': 160129.0, 'sum': 797107.0}, 'EL15_pos_1384': {'bp': 167725.0, 'sum': 862940.0}, 'EL09_pos_1384': {'bp': 173863.0, 'sum': 866517.0}, 'EL04_pos_1390': {'bp': 166335.0, 'sum': 945398.0}, 'EL13_pos_1379': {'bp': 139434.0, 'sum': 748259.0}, 'EL12_pos_1384': {'bp': 116873.0, 'sum': 772482.0}, 'EL10_pos_1384': {'bp': 134178.0, 'sum': 717360.0}, 'EL23_pos_1383': {'bp': 178572.0, 'sum': 850229.0}, 'EL18_pos_1383': {'bp': 178875.0, 'sum': 1011611.0}, 'EL11_pos_1385': {'bp': 141504.0, 'sum': 724488.0}, 'EL21_pos_1384': {'bp': 145997.0, 'sum': 811833.0}, 'EL20_pos_1377': {'bp': 155857.0, 'sum': 821971.0}, 'EL24_pos_1385': {'bp': 135198.0, 'sum': 700679.0}, 'EL17_pos_1379': {'bp': 181651.0, 'sum': 1042127.0}, 'EL06_pos_1384': {'bp': 190627.0, 'sum': 1148794.0}, 'EL05_pos_1384': {'bp': 167229.0, 'sum': 1078927.0}, 'EL19_pos_1384': {'bp': 158846.0, 'sum': 966917.0}, 'EL02_pos_1384': {'bp': 148764.0, 'sum': 974191.0}, 'EL07_pos_1384': {'bp': 156434.0, 'sum': 788697.0}, 'EL08_pos_1383': {'bp': 177628.0, 'sum': 837860.0}}
COMMENT: RETENTION_TIME_STDEV 0.006
COMMENT: PRECURSOR_M/Z_RAW 199.107814
COMMENT: PRECURSOR_M/Z_STDEV 0.000093
COMMENT: PRECURSOR_IN_MS1 mz 199.107578; int 55.726; delta(ppm) 1.057226
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.697; C9H14N2O3; [M+H]+; delta(ppm) -0.696617
COMMENT: PROPOSED_MF MS-FINDER 3.409; C9H14N2O3; [M+H]+; delta(ppm) -0.696906
COMMENT: PROPOSED_MF SIRIUS5_Sirius 6.782; C9H14N2O3; [M+H]+; delta(ppm) -0.696906
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C9H14N2O3; [M+H]+; delta(ppm) -0.696906
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.165; C9H14N2O3; [M+H]+; delta(ppm) -0.696906
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.776; C7H12N5O2; [M+H]+; delta(ppm) 6.046538
COMMENT: PROPOSED_MF SIRIUS6_Sirius 1.134; C5H17N3O3P; [M+H]+; delta(ppm) -2.249344
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.194; C6H15FN2O4; [M+H]+; delta(ppm) -6.435742
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.592; C7H16F2N2S; [M+H]+; delta(ppm) 0.391964
COMMENT: PROPOSED_MF SIRIUS6_Sirius -1.361; C3H15N6O2P; [M+H]+; delta(ppm) 4.494079
COMMENT: PROPOSED_MF SIRIUS6_Sirius -4.363; C2H14N8OS; [M+H]+; delta(ppm) -4.141260
COMMENT: PROPOSED_MF SIRIUS6_Sirius -10.991; H12N11S; [M+H]+; delta(ppm) 2.602137
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.997; C9H14N2O3; [M+H]+; delta(ppm) -0.696906
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.003; C7H12N5O2; [M+H]+; delta(ppm) 6.046538
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.536; UBLWFFBGMBRBMC-UHFFFAOYSA-N; [M+H]+; O=C1NC(C(=O)N2CCCC12)C(O)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.486; IAFZDRRKGPWSHG-UHFFFAOYSA-N; [M+H]+; O=C(N1CC2OCC(=O)N(C)C2C1)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.411; HHLXJTDUHFBYAU-UHFFFAOYSA-N; [M+H]+; CCC1(C(C)C)C(=O)NC(=O)NC1=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.397; ZGUYPJJFHYFLBV-UHFFFAOYSA-N; [M+H]+; COC(=O)NC1=NOC(=C1)C(C)(C)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.391; FWJKNZONDWOGMI-UHFFFAOYSA-N; [M+H]+; CCC1(CC)C(=O)NC(=O)N(C)C1=O
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.504; FWJKNZONDWOGMI-UHFFFAOYSA-N; [M+H]+; Metharbital
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.336; KIUSNPVZHFRLAJ-UHFFFAOYNA-N; [M+H]+; Pedatisectine D
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.272; GXNDDRVCUBWYBN-BQBZGAKWSA-N; [M+H]+; Xestostreptin
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.255; HHLXJTDUHFBYAU-UHFFFAOYSA-N; [M+H]+; UNPD25720
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.232; IAFZDRRKGPWSHG-UHFFFAOYSA-N; [M+H]+; 6-acetyl-4-methyl-octahydropyrrolo[3,4-b][1,4]oxazin-3-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.220; UBLWFFBGMBRBMC-UHFFFAOYSA-N; [M+H]+; Cyclo(Pro-Thr)
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.200; PFPUZMSQZJFLBK-UHFFFAOYSA-N; [M+H]+; 2-(2-oxoimidazolidin-1-yl)ethyl methacrylate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.200; JFHAMNVZHGKQDQ-UHFFFAOYSA-N; [M+H]+; ethyl 4,6-dimethyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.171; UXORSOFXUKJTFE-UHFFFAOYSA-N; [M+H]+; cis 8-methoxy-1,3-diazaspiro[4.5]decane-2,4-dione sodium salt
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.128; ZGUYPJJFHYFLBV-UHFFFAOYSA-N; [M+H]+; Carboxazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; ZGUYPJJFHYFLBV-UHFFFAOYSA-N; [M+H]+; Carboxazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.948; FWJKNZONDWOGMI-UHFFFAOYSA-N; [M+H]+; Metharbital
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.948; UXORSOFXUKJTFE-UHFFFAOYSA-N; [M+H]+; cis 8-methoxy-1,3-diazaspiro[4.5]decane-2,4-dione sodium salt
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.473; PFPUZMSQZJFLBK-UHFFFAOYSA-N; [M+H]+; 2-(2-oxoimidazolidin-1-yl)ethyl methacrylate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.473; IAFZDRRKGPWSHG-UHFFFAOYSA-N; [M+H]+; 6-acetyl-4-methyl-octahydropyrrolo[3,4-b][1,4]oxazin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.473; UBLWFFBGMBRBMC-UHFFFAOYSA-N; [M+H]+; Cyclo(Pro-Thr)
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; KIUSNPVZHFRLAJ-UHFFFAOYNA-N; [M+H]+; Pedatisectine D
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; HHLXJTDUHFBYAU-UHFFFAOYSA-N; [M+H]+; UNPD25720
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; GXNDDRVCUBWYBN-BQBZGAKWSA-N; [M+H]+; Xestostreptin
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; JFHAMNVZHGKQDQ-UHFFFAOYSA-N; [M+H]+; ethyl 4,6-dimethyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.620; FWJKNZONDWOGMI-UHFFFAOYSA-N; [M+H]+; 5,5-diethyl-1-methyl-1,3-diazinane-2,4,6-trione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.888; ZGUYPJJFHYFLBV-UHFFFAOYSA-N; [M+H]+; methyl N-(5-tert-butyl-1,2-oxazol-3-yl)carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.168; FQZRHFMUTKJTFW-UHFFFAOYSA-N; [M+H]+; 2-methoxy-2,8-diazaspiro[4.5]decane-1,3-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.045; FGVDKIGUEQOVMW-UHFFFAOYSA-N; [M+H]+; 3-(hydroxymethyl)-1,3-diazaspiro[4.5]decane-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.974; HMYFWMSOVPGNGT-UHFFFAOYSA-N; [M+H]+; methyl 1-oxa-2,8-diazaspiro[4.5]dec-2-ene-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.930; PFPUZMSQZJFLBK-UHFFFAOYSA-N; [M+H]+; 2-(2-oxoimidazolidin-1-yl)ethyl 2-methylprop-2-enoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.847; HHLXJTDUHFBYAU-UHFFFAOYSA-N; [M+H]+; 5-ethyl-5-propan-2-yl-1,3-diazinane-2,4,6-trione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.789; UXORSOFXUKJTFE-UHFFFAOYSA-N; [M+H]+; 8-methoxy-1,3-diazaspiro[4.5]decane-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.787; ALVDHBGUJHQGNC-UHFFFAOYSA-N; [M+H]+; 1,5-dimethyl-5-propan-2-yl-1,3-diazinane-2,4,6-trione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.778; VYLYDBUMNXTJNN-UHFFFAOYSA-N; [M+H]+; 8,13-dioxa-2,11-diazadispiro[3.0.55.34]tridecan-12-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.771; RDAIBCNBTCENKD-UHFFFAOYSA-N; [M+H]+; 2-(2-oxo-4-prop-2-enoxypyrrolidin-1-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.685; YQXGXEUSFRFHRR-UHFFFAOYSA-N; [M+H]+; 1-(morpholin-4-ylmethyl)pyrrolidine-2,5-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.652; YJLDVCLFARYUGI-UHFFFAOYSA-N; [M+H]+; methyl 1-(azetidin-3-yl)-5-oxopyrrolidine-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.603; ZUHYFPMWZVPVHD-UHFFFAOYSA-N; [M+H]+; 2-[2-(2-methylpropyl)-3-oxo-1H-pyrazol-5-yl]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.501; HXPLRFNNPINGHP-QMMMGPOBSA-N; [M+H]+; N-[2-[(2S)-2-formylpyrrolidin-1-yl]-2-oxoethyl]acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.498; FHSXRWUPFJOQNQ-UHFFFAOYSA-N; [M+H]+; 1-(2-methylpropyl)-6-oxo-4,5-dihydropyridazine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.470; MYXYKEABCCIJEX-BJMVGYQFSA-N; [M+H]+; 2-[5-[(E)-methoxyiminomethyl]-3,6-dihydro-2H-pyridin-1-yl]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.470; DDKZZYDTARWAND-UXBLZVDNSA-N; [M+H]+; methyl 5-[(E)-methoxyiminomethyl]-3,6-dihydro-2H-pyridine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.220; XIBUBTQSOGWALU-UHFFFAOYSA-N; [M+H]+; 5-ethyl-5-propyl-1,3-diazinane-2,4,6-trione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.172; DEEDXIVCNOOEAV-UHFFFAOYSA-N; [M+H]+; (3,4,5-trimethoxyphenyl)hydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.171; QSELDKYOARDOCZ-UHFFFAOYSA-N; [M+H]+; 5-pentan-2-yl-1,3-diazinane-2,4,6-trione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.167; UDOOPVQAORZPMV-UHFFFAOYSA-N; [M+H]+; 1,3-dimethyl-5-propan-2-yl-1,3-diazinane-2,4,6-trione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.167; XRSLXDDGKNZMMM-UHFFFAOYSA-N; [M+H]+; tert-butyl N-(4-methyl-1,3-oxazol-5-yl)carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.167; SXUSSJBFZUZNSX-UHFFFAOYSA-N; [M+H]+; 3-(2-hydroxyethyl)-1,3-diazaspiro[4.4]nonane-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.167; GWBFJJQNFCHKNQ-UHFFFAOYSA-N; [M+H]+; 4,5-bis(prop-2-enoxy)imidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.167; GIVGVNLRHLKCMH-DAXSKMNVSA-N; [M+H]+; (Z)-N-(acetylcarbamoyl)-2-ethylbut-2-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.167; NNGFUHPRRCAMOK-UHFFFAOYSA-N; [M+H]+; 4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)butanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.167; VKXWNDWYGSUDQN-UHFFFAOYSA-N; [M+H]+; 3-(3-tert-butyl-1,2,4-oxadiazol-5-yl)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.167; VHCBSNJAXKWWRN-UHFFFAOYSA-N; [M+H]+; tert-butyl N-(2-methyl-1,3-oxazol-4-yl)carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.167; NLAYNQZOCODFEP-UHFFFAOYSA-N; [M+H]+; ethyl 5-methoxy-1,4-dimethylpyrazole-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.167; ZYSOXRVUVDAUCQ-UHFFFAOYSA-N; [M+H]+; tert-butyl N-(2-methyl-1,3-oxazol-5-yl)carbamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -213.436; UBLWFFBGMBRBMC; [M+H]+; (3S,8aS)-3-[(1R)-1-hydroxyethyl]-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -234.815; HXPLRFNNPINGHP; [M+H]+; Acetyl-glycyl-prolinal
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -258.265; KBUBTZMZSVZFQU; [M+H]+; 3-[3-(2-cyanoethoxy)-2-hydroxypropoxy]propanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -282.569; WPDJMBAXQKFEOI; [M+H]+; 5-(morpholine-4-carbonyl)pyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -290.693; DGQBDXFRBIXHDR; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -305.182; YQXGXEUSFRFHRR; [M+H]+; Oprea1_273023
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -308.966; RDAIBCNBTCENKD; [M+H]+; 1-Pyrrolidineacetamide, 2-oxo-4-(2-propenyloxy)-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -311.487; HHLXJTDUHFBYAU; [M+H]+; Vasalgin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -317.981; KIUSNPVZHFRLAJ; [M+H]+; 4-(3-methylpyrazin-2-yl)butane-1,2,3-triol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -318.074; QSELDKYOARDOCZ; [M+H]+; 5-(sec-Pentyl)barbituric acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -342.204; IAFZDRRKGPWSHG; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -347.075; GIVGVNLRHLKCMH; [M+H]+; Homeostan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -348.272; GWBFJJQNFCHKNQ; [M+H]+; 4,5-Bis(allyloxy)-2-imidazolidinone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -358.306; PFPUZMSQZJFLBK; [M+H]+; 2-(2-Oxoimidazolidin-1-yl)ethyl methacrylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -362.712; UDOOPVQAORZPMV; [M+H]+; 1,3-Dimethyl-5-isopropylbarbituric acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -369.534; ALVDHBGUJHQGNC; [M+H]+; 1,5-Dimethyl-5-isopropylbarbituric acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -373.976; FWJKNZONDWOGMI; [M+H]+; Endiemal
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -383.231; JFHAMNVZHGKQDQ; [M+H]+; Oprea1_388948
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -432.576; SXUSSJBFZUZNSX; [M+H]+; 5-24-07-00272 (Beilstein Handbook Reference)
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -438.988; GXNDDRVCUBWYBN; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -444.610; DDKZZYDTARWAND; [M+H]+; Methyl (E)-3,6-dihydro-5-((methoxyimino)methyl)-1(2H)-pyridinecarboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -447.702; ZUWLNOXNQWRSHI; [M+H]+; 3-(2-ethenoxyethyl)-5,5-dimethylimidazolidine-2,4-dione
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -467.913; UXORSOFXUKJTFE; [M+H]+; 8-methoxy-1,3-diazaspiro[4.5]decane-2,4-dione
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -523.447; FGVDKIGUEQOVMW; [M+H]+; 3''-(Hydroxymethyl)cyclohexanespiro-5''-hydantoin
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.382; UBLWFFBGMBRBMC; [M+H]+; (3S,8aS)-3-[(1R)-1-hydroxyethyl]-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -263.676; UDOOPVQAORZPMV; [M+H]+; Barbituric acid, 1,3-dimethyl-5-isopropyl-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -278.642; GIVGVNLRHLKCMH; [M+H]+; Urea, 1-acetyl-3-(2-ethylcrotonyl)-, (Z)-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -294.317; ZUHYFPMWZVPVHD; [M+H]+; 2-[1-(2-methylpropyl)-5-oxo-2,5-dihydro-1H-pyrazol-3-yl]acetic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -311.671; QSELDKYOARDOCZ; [M+H]+; 5-(sec-Pentyl)barbituric acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -327.456; HHLXJTDUHFBYAU; [M+H]+; 5-ethyl-5-(propan-2-yl)-1,3-diazinane-2,4,6-trione
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -334.439; ALVDHBGUJHQGNC; [M+H]+; 1,5-Dimethyl-5-isopropylbarbituric acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -336.793; DDKZZYDTARWAND; [M+H]+; Methyl (E)-3,6-dihydro-5-((methoxyimino)methyl)-1(2H)-pyridinecarboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -345.015; KBUBTZMZSVZFQU; [M+H]+; 3,3'-[(2-Hydroxypropane-1,3-diyl)bis(oxy)]bispropiononitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -364.588; FWJKNZONDWOGMI; [M+H]+; Metharbital
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -371.242; ZUWLNOXNQWRSHI; [M+H]+; 5,5-Dimethyl-3-(2-(vinyloxy)ethyl)imidazolidine-2,4-dione
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.035; UDOOPVQAORZPMV; [M+H]+; Barbituric acid, 1,3-dimethyl-5-isopropyl-
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C9H15N2O3; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 2.226
MS$FOCUSED_ION: PRECURSOR_M/Z 199.107580
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-052b-9810000000-dce96dcd219608cbbaf1
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  55.0180244 17.2558 55.018732 1.0360 5.58 -0.2821 15 f{C3H3O1}/3.33ppm,p-C6H12N2O2
  55.0545136 126.7637 55.055221 0.4904 21.00 0.2429 21 f{C4H7}/5.21ppm,p-C5H8N2O3
  57.0337297 17.5536 57.034446 0.9468 5.18 0.3750 15 f{C3H5O1}/4.18ppm,p-C6H10N2O2
  57.0701464 226.7917 57.070863 0.4556 36.05 0.2688 21 f{C4H9}/4.73ppm,p-C5H6N2O3
  58.0653745 604.4077 58.066095 0.3100 29.97 0.9273 21 f{C3H8N1}/4.29ppm,p-C6H7N1O3
  59.0686841 18.1140 59.069408 1.1343 3.43 0.2226 20 ?
  67.0543623 49.5543 67.055104 1.4018 8.95 0.1078 21 f{C5H7}/2.02ppm,p-C4H8N2O3
  69.0335097 18.0125 69.034253 0.7677 5.56 -0.1143 15 f{C4H5O1}/0.27ppm,p-C5H10N2O2
  69.0700365 96.1864 69.070780 0.5502 16.97 0.2752 20 f{C5H9}/2.31ppm,p-C4H6N2O3
  71.0492268 43.5174 71.049970 1.0838 7.14 0.1940 20 f{C4H7O1}/1.20ppm,p-C5H8N2O2
  71.0856258 24.6934 71.086369 1.3927 8.56 -0.2150 20 f{C5H11}/1.39ppm,p-C4H4N2O3
  72.0444871 56.4836 72.045230 0.9994 13.89 0.1351 21 f{C3H6N1O1}/1.34ppm,p-C6H9N1O2
  74.0965273 400.9716 74.097269 0.3779 66.30 0.2805 21 f{C4H12N1}/1.37ppm,p-C5H3N1O3
  79.0542420 20.7692 79.054974 1.3788 5.20 -0.0860 19 f{C6H7}/0.19ppm,p-C3H8N2O3
  81.0699565 69.4613 81.070683 1.0115 12.24 0.2857 21 f{C6H9}/0.98ppm,p-C3H6N2O3
  83.0855678 80.2079 83.086287 0.9268 16.85 0.0939 18 f{C6H11}/0.49ppm,p-C3H4N2O3
  85.0647504 21.0264 85.065462 1.1638 7.35 -0.0836 18 f{C5H9O1}/-0.48ppm,p-C4H6N2O2
  88.0756742 35.5260 88.076371 1.1694 8.82 -0.2647 20 f{C4H10N1O1}/-0.18ppm,p-C5H5N1O2
  93.0698185 26.3077 93.070485 1.4505 6.65 -0.1766 21 f{C7H9}/-0.63ppm,p-C2H6N2O3
  95.0855331 54.7301 95.086185 0.9255 10.19 0.3203 20 f{C7H11}/0.07ppm,p-C2H4N2O3
  97.0284139 62.9941 97.029051 0.8657 18.33 0.2468 21 f{C5H5O2}/0.08ppm,p-C4H10N2O1
  97.1011371 28.8308 97.101774 1.0299 7.34 -0.1368 20 f{C7H13}/-0.41ppm,p-C2H2N2O3
  99.0440596 27.8579 99.044680 1.5044 8.31 -0.3930 19 f{C5H7O2}/0.04ppm,p-C4H8N2O1
  100.0756848 121.3218 100.076297 0.8194 21.68 0.1727 21 f{C5H10N1O1}/-0.06ppm,p-C4H5N1O2
  102.0913210 19.3890 102.091914 1.5476 6.60 -0.0412 16 f{C5H12N1O1}/-0.19ppm,p-C4H3N1O2
  105.0334252 19.6925 105.033989 1.3710 6.82 0.0559 16 f{C7H5O1}/-0.63ppm,p-C2H10N2O2
  107.0854777 26.4182 107.086020 1.1299 7.04 0.2351 19 f{C8H11}/-0.46ppm,p-C1H4N2O3
  109.1011169 27.5187 109.101646 0.9899 7.51 0.0557 20 f{C8H13}/-0.55ppm,p-C1H2N2O3
  110.0713297 310.9150 110.071851 0.6360 219.82 0.5844 21 ?
  116.9661450 37.0814 116.966612 0.8977 7.27 0.0123 17 ?
  123.0440573 37.4241 123.044467 1.0728 13.55 -0.0857 21 f{C7H7O2}/0.01ppm,p-C2H8N2O1
  141.0546163 82.0699 141.054893 0.8933 18.12 0.2903 20 f{C7H9O3}/-0.03ppm,p-C2H6N2
  151.1116689 27.5210 151.111973 0.7610 9.95 -0.0333 19 ?
  152.0818176 76.3521 152.082124 0.7430 57.87 0.6346 20 f{C9H12O2}/-8.97ppm,p-H3N2O1
  155.9748615 48.0346 155.975179 1.2310 10.85 -0.3464 15 ?
  156.0767993 84.1573 156.077117 0.8201 63.74 0.4632 19 f{C8H12O3}/-8.31ppm,p-C1H3N2
  170.9769567 28.3120 170.977317 1.1697 8.22 -0.1538 18 ?
  177.9563348 35.5238 177.956716 1.4779 10.62 -0.1474 20 ?
  179.1065281 44.9399 179.106912 1.3121 12.40 0.1476 18 ?
  197.1169695 40.0966 197.117409 1.2429 12.54 0.4912 16 ?
  198.1852337 21.7047 198.185677 1.7307 7.24 -0.1203 20 ?
  199.1076895 999.0000 199.108136 0.3265 0.00 1.0000 21 f{C9H15N2O3}/-0.15ppm,p
  200.1118277 86.6355 200.112277 1.3093 9.17 0.6961 17 ?
  200.2007479 196.2000 200.201197 0.6643 38.09 0.1727 21 ?
PK$NUM_PEAK: 44
PK$PEAK: m/z int. rel.int.
  55.018024 17.26 17
  55.054514 126.76 126
  57.033730 17.55 17
  57.070146 226.79 226
  58.065374 604.41 604
  59.068684 18.11 18
  67.054362 49.55 49
  69.033510 18.01 18
  69.070037 96.19 96
  71.049227 43.52 43
  71.085626 24.69 24
  72.044487 56.48 56
  74.096527 400.97 400
  79.054242 20.77 20
  81.069957 69.46 69
  83.085568 80.21 80
  85.064750 21.03 21
  88.075674 35.53 35
  93.069819 26.31 26
  95.085533 54.73 54
  97.028414 62.99 62
  97.101137 28.83 28
  99.044060 27.86 27
  100.075685 121.32 121
  102.091321 19.39 19
  105.033425 19.69 19
  107.085478 26.42 26
  109.101117 27.52 27
  110.071330 310.92 310
  116.966145 37.08 37
  123.044057 37.42 37
  141.054616 82.07 82
  151.111669 27.52 27
  152.081818 76.35 76
  155.974862 48.03 48
  156.076799 84.16 84
  170.976957 28.31 28
  177.956335 35.52 35
  179.106528 44.94 44
  197.116970 40.10 40
  198.185234 21.70 21
  199.107689 999.00 999
  200.111828 86.64 86
  200.200748 196.20 196
//
